COMPANY PROFILE

Qingdao Riskell Biotechnology

Explore full profile

ChinaFounded 2016Biotech & Life Sciences

Valuation $50–100M Last recorded · 2023

Total funding $10–50M Disclosed equity funding

Unlock exact values

At a glance

Status: Operational
Founded: 2016
Headquarters: China
Open positions: None listed
Dealroom signal: 16.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Nov 2023	$14M	$55M	Qingdao Jufeng Science & Technology Venture Investment · CICC · CITIC Medical · Chongqing Yinuo	↗
SPINOUT✓Other financing	Jan 2016	$0	—	Yellow Sea Fisheries Research Institute	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Qingdao Riskell Biotechnology website traffic

Latest recorded traffic for Qingdao Riskell Biotechnology is 210 monthly website visits, down 68.7% over the last three months.

Latest monthly visits210 3-month web change-68.7%

Monthly website visitsNov 2023–Apr 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SPSorriso PharmaceuticalsA biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases	San Diego, United States	Operational	14	$31M	$124M
ITIntegra TherapeuticsIntegra Therapeutics is a biotech company developing next-generation gene writing tools to cure genetic diseases	Barcelona, Spain	Operational
TTTHEON TherapeuticsA biopharmaceutical company developing small molecules that inhibit the immunosuppressive cancer signaling pathways	Cambridge, United States	Operational
PUPulmobioticsDiscovers and develops novel treatments and vaccines for respiratory diseases	Barcelona, Spain	Operational
DIDiamanteA national company that specializes in cleaning and maintenance services	Verona, Italy	Operational
CTC4 TherapeuticsC4 is building on the knowledge with synthetic chemical compounds	Watertown, United States	Operational
EBEpsilon-3 BioFocused on the efficient development of first in class drug candidates stimulating safe removal of cellular debris	Babraham, United Kingdom	Operational
STSingle TechnologiesThree-dimensional DNA sequencing technology for high-throughput genomics	Stockholms kommun, Sweden	Operational

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

QIQingdao Jufeng Science & Technology Venture Investment
CICICC
CMCITIC Medical
CYChongqing Yinuo

Other known investors1 additional known investor

YIYellow Sea Fisheries Research Institute

Talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

🇨🇳 China HQ

Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Qingdao Riskell Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Qingdao Riskell Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.